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Purpose: The objective was to determine the long-term survival rates of patients who 
undergo distal arterial bypass urgery and to identify the preoperative factors that are 
predictive of survival. 
Methods: Three hundred fifty-eight consecutive in situ distal leg bypass procedures were 
performed between July 1986 and December 1995. The relationship between 13 preop- 
erative variables and late survival were determined using both univariate (Kaplan-Meier) 
and multivariate (Cox regression) statistical techniques. 
Results: The cumulative survival rates at 1, 3, 5, and 7 years were 86.6% + 2.0%, 63.2% + 
3.0%, 46.9% + 3.4%, and 35.3% -+ 3.8%, respectively. Using Cox regression, four 
significant variables were found to be associated with lower late survival rates: male 
gender, diabetes, chronic renal insufficiency (patients with creatinine levels greater than 
or equal to 1.7 mg/dl  or 150 SI units), and a history of cerebrovascular disease (p < 
0.001 for model). When none of these four variables were present, the predicted 5-year 
survival rate was 71%, whereas the survival rate was reduced to 43% to 60% when one was 
present, 23% to 42% when two were present, 8% to 22% when three were present, and 2% 
when all four were present. 
Conclusions: This study defines the long-term survival rates in a cohort of patients after 
undergoing distal bypass urgery and demonstrates that certain preoperative factors are 
predictive of late survival. Knowledge of these factors may be useful to assist in individual 
operative decisions between aggressive attempts at distal revascularization versus primary 
amputation. (J Vase Surg 1997;25:899-904.) 
The long-term patency rates for autologous a- 
phenous vein distal bypass grafts are well established, 
and most patients who have an appropriate indica- 
tion are considered suitable surgical candidates? -6 
The cost of treating patients who have critical isch- 
emia, particularly with respect o the use of hospital 
resources, is significant. 7-9 Most notable is the impact 
on length of stay. 1° The current emphasis on cost 
containment has underscored the importance of 
achieving not only long-term graft patency but also 
maintaining or improving function. Unfortunately, 
there is sparse surgical iterature that addresses the 
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endpoints of functional outcome. Using the RAND 
36-Item Health Survey, Duggan et al. H found that 
the functional scores of patients who underwent am- 
putation were not significantly different from those 
who underwent successful revascularization proce- 
dures; hence, primary amputation may be an option 
for patients who have a short life expectancy or are 
not likely to achieve a good functional result. 
Thus, in addition to considering technical success 
and functional outcome, long-term patient survival 
rates are also an important consideration during pre- 
operative decisionmaking. The purpose of this paper 
was to determine the late survival rate of a large, 
consecutive cohort of patients who underwent arte- 
rial bypass procedures with in situ vein grafts and, 
using multivariate analysis, to determine the preoper- 
ative variables that predict long-term survival. 
METHODS 
Demographic data and outcome variables were 
collected prospectively in a consecutive group of pa- 
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Table I. Demographic data for 358 
consecutive patients who underwent 
in situ bypass 
Age 
mean -+ SD 
median 
Gender 
68 + 10 years 
69 years 
68% male 
32% female 
Smoking history (past 10 years) 68% 
Diabetes 38% 
Coronary disease 47% 
(history of MI, angina, CHF) 
Cerebrovascular disease 20% 
(history of TIA, stroke) 
Pulmonary disease 12% 
(COPD, pCO 2 > 50, pO 2 < 60) 
Renal insufficiency 12% 
Prior ipsilateral surgery 20% 
Indication: 
grade 0 (popliteal neurysm) 1% 
grade 1 (daudication) 20% 
grade 2 (ischemic rest pain) 39% 
grade 3 (ulcer, gangrene) 40% 
Timing: 
elective 92% 
emergency 8% 
Proximal anastomosis: 
common femoral 55% 
superficial femoral 33% 
profunda 2% 
proximal inflow graft 10% 
Distal anastomosis: 
below knee popfiteal 32% 
tibial 68% 
inframalleolar 30% 
Mean preoperative ABI 0.35 -+ 0.21 
Mean postoperative ABI 0.84 + 0.34 
M/, Myocardial infarction; CHF, congestive heart failure; TIA, 
transient ischemic attack; COPD, chronic obstructive pulmonary 
disease; ABI, ankle-brachial index. 
tients who underwent in situ vein leg bypass proce- 
dures. These variables wcrc defined according to the 
criteria prepared by the Ad Hoc Committee on Re- 
porting Standards. 12 Postoperative follow-up (clini- 
cal and vascular laboratory surveillance) was con- 
ducted every 3 months during the first postoperative 
year and every 6 months thereafter. Graft patency 
was determined at each visit, and survival status and 
canse of death was determined by contact with the 
referring physician or family. The angiographic run- 
off score (Ad Hoc Committee on Reporting Stan- 
dards 12) ranges from 1 (best runoff) to 10 (worst 
runoff). For subgroup analysis, the median runoff 
score was determined (runoff score, 5), and patients 
were categorized as poor runoff (score -> 5) and 
good runoff(score < 5). 
Cumulative graft patency and patient survival 
rates were determined using the Kaplan-Meier meth- 
od? 3,14 The relationship between 13 preoperative 
Table I I .  Perioperative morbidity and 
mortality data 
Mortality rate (n = 4, all cardiac) 1.1% 
Myocardial infarct (major) 5.0% 
Stroke or TIA 1.7% 
Hemorthage/hematoma not requiring surgery 3.7% 
Lymphocele/lymph leak 4.3% 
Womld infection 20.7% 
superficial 12.3% 
deep 8.4% 
TIA, Transient ischemic attack. 
Table I I I .  Incidence of late death of distal 
bypass group compared with 
Canadian population 23 
Canadian 
Cause Distal bypass population 
Cardiovascular 70.8% 39% 
Disease 
Cardiac 62.6% 
Stroke 8.2% 
Pulmonary 4.0% 8% 
Renal 8.2% 
Malignancy 10.2% 28% 
Other 6.8% 
variables and survival was analyzed using both uni- 
variate (Kaplan-Meier) and multivariate (Cox regres- 
sion) statistical techniques. For each variable, the 
Kaplan-Mcicr method was used to determine the 
cumulative survival rate and the log-rank test (Man- 
tel) was uscd to specify statistical differences between 
the subgroups. 1~ The stepwise Cox proportional 
hazards model was used for the multivariate analysis 
of the preoperative factors that were predictive of late 
survival. 16 For comparison, survival data were ob- 
tained from published life tables for the age and 
gender-matched Ontario population. 17,~8 
RESULTS 
Three hundred fifty-eight in situ vein leg bypass 
procedures (116 [ 32%] below-knee femoropopliteal 
and 242 [68%] tibia] bypass) were performed at the 
Toronto Hospital between July 1, 1986, and De- 
cember 31, 1995. They represented 56% of our in- 
frainguinal bypass procedures (autogenous and pros- 
thetic) performed during this time period. There 
were also 140 procedures (22%) performed with re- 
versed or nonreversed saphenous vein grafts and 138 
(22%) with polytetrafluoroethylene (PTFE) grafts. 
This article reports the prospective data collected for 
the patients who underwent in situ bypass proce- 
dures because we have had a particular interest in the 
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Table IV. Preoperative variables and 
association with long-term survival 
(Kaplan-Meier) by univariate analysis 
Variable p 
Gender (male vs female) 0.035 
Surgeon (n = 4) 0.001 
Timing of surgery (elective vs emergency) 0.935 
Diabetes ( IDDM or N IDDM vs nil) 0.001 
Smoking history (within past 10 years vs nil) 0.136 
Coronary artery disease (MI, angina, CHF vs nil) 0.004 
Cerebrovascular disease (past TIA, sn-oke vs nil) 0.002 
Respiratory disease (COPD vs nil) 0.565 
Renal insuffieiency (abnormal creatinine vs nil) 0.00I 
Indication for surgery (critical ischemia vs nil) 0.037 
Previous vascular econstruction (yes vs no) 0.074 
Distal anastomosis (popliteal vs tibial) 0.048 
Runoff index < 5 (i.e. median index; yes vs no) 0.094 
Differences between variable subgroups determined by log-rank 
test (Mantel). Those variables with a p value less than 0.10 were 
selected in a stepwise fashion for inclusion into the multivariate 
model. 
IDDM, Insulin-dependent diabetes mellitus; NIDDM, non-insu- 
lin-dependent diabetes mellitus; MI, myocardial infarction; CHF, 
congestive heart failure, TIA, transient ischemic attack; COPD, 
chronic obstructive pulmonary disease. 
Table V. Independent predictors of 
long-term survival 
Covariate Coefficient SD p 
Gender (male = 1; female = 0) 0.545 0.193 0.005 
Diabetes (yes = 1; no = 0) 0.537 0.171 0.002 
Renal insufficiency 0.906 0.231 0.001 
(creatinine > 1.7 mg%) 
(yes = 1;no = 0) 
History ofcerebrovascular 0.387 0.196 0.048 
disease (yes = 1; no = 0) 
Variables with a p value < 0.10 with the univariate analysis were 
selected in a stepwise fashion for inclusion into the multivariate 
Cox regression model (p = 0.001 for model). 
in situ technique and have followed the demographic 
and operative results in this subgroup in a prospec- 
tive fashion. The reversed vein, nonreversed vein, 
and PTFE bypass grafts have not been observed in a 
similar fashion. 
The demographic data are summarized in Table 
I, and the perioperative morbidity and mortality data 
are summarized in Table II. 
Secondary patency and late survival data. The 
cumulative secondary patency rates at 1, 3, 5, and 7 
years were 85.0% + 1.9%, 81.4% + 2.2%, 78.4% + 
2.6%, and 78.4% + 2.6%, respectively. There were 
four deaths in the perioperative period (within 30 
days of  surgery or during the hospital admission), for 
an operative mortality rate of 1.1%. 
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Fig. 1. Cumulative survival data of patients who under- 
went in situ bypass grafts, and comparison with age and 
gender-matched Ontario population. 
The causes for late death are summarized in Ta- 
ble III. The most common cause was a cardiac event 
(62.6%). The cumulative survival rates at 1, 3, 5, and 
7 years were 86.6% + 2.0%, 63.2% _+ 3.0%, 46.9% + 
3.4%, and 35.3% _+ 3.8%, respectively (Fig. 1). The 
cumulative survival rate of these patients was signifi- 
cantly lower (p < 0.001) than the age and gender- 
matched Ontario population for the same time pe- 
riod (Fig. 1). 
Preoperative factors associated with late sur- 
vival. The significant variables associated with late 
survival and their p values are summarized in Table 
IV. Using stepwise multivariate analysis (Cox regres- 
sion), the independent predictors for late survival 
were determined. As listed in Table V, there were 
four significant variables associated with lower late 
survival rates: male gender, diabetes, chronic renal 
insufficiency, and a history of cerebrovascular disease 
(p < 0.001 for model). The predicted survival rates 
for these four variables are shown in Fig. 2, A to D. 
Table VI and Fig. 3 summarize the predicted survival 
rates for the 16 combinations of  the variables. Note 
that when none of  these variables were present, tile 
predicted 5-year survival rate was 71%, whereas the 
survival rate was reduced to 43% to 60% when one 
was present, 23% to 42% when two were present, 8% 
to 22% when three were present, and 2% when all 
four were present. 
D ISCUSSION 
Meticulous operative techniques combined with 
postoperative graft surveillance are the two main 
factors that are responsible for the improvement in
long-term patency rates after both in situ and re- 
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Fig. 2. Independent predictors of long-term survival: A, gender; B, diabetes; C, renal insuffi- 
ciency (patients with creatine l vels < or > 1.7 mg/dl  ); D, history of cerebrovascular disease. 
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versed saphenous vein bypass grafts. >6 Although 
some believe that all patients who have critical limb 
ischemia should undergo an attempt at revasculariza- 
tion, in the present climate of cost containment o her 
factors must be considered in addition to operability 
by angiographic riteria. 7sa0 The decision for pri- 
mary amputation is only straightforward when faced 
with a patient who has extreme cardiac, respiratory, 
or cerebrovascular disease, or whose poor cognitive 
status dictates only palliation of rest pain or distal 
infection. Although there are several reports that 
summarize technical success, there are few references 
in the surgical literature that deal with functional 
outcome after infrainguinal bypass urgery. Duggan 
and associates 11evaluated the functional outcomes 
of limb salvage surgery by administering the RAND 
36-Item Health Survey as a health assessment tool. 
Although they reported an 80% limb salvage rate, 
only 50% of patients urvived at 3 years and only 25% 
survived with the salvaged extremity and were ambu- 
latory. This finding clearly emphasizes that patency 
alonc is an inadequate endpoint for operative success 
and that more information is necessary to help with 
our preoperative decisionmaking. 
In patients who undergo infrainguinal bypass 
grafting procedures, the likelihood of long-term sur- 
vival may be important in the preoperative decision 
process of certain individual patients. In recent re- 
ports, the 5-year survival rate has ranged from 38% to 
66%, with death most commonly aresult of coronary 
or cerebrovascular discascJ 9-22 The cumulative 5- 
and 7-year survival rates in our entire cohort of pa- 
tients were 46.9% -+ 3.4% and 35.3% + 3.8%, respec- 
tively. The detailed multivariate analysis was con- 
ducted to determine which variables, alone or in 
combination, would be useful in estimating late sur- 
vival rates. The four significant independent predic- 
tors were male gender, diabetes, chronic renal insuf- 
ficiency, and a history of cerebrovascular disease. We 
recognize the possibility of bias because of the inclu- 
sion of  only patients who underwent in situ vein 
bypass grafting procedures, and we caution the 
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Tab le  V I .  Predicted 1 and 5-year survival 
data for all combinat ions o f  significant 
variables by Cox regression 
Cumulative survival rates 
A B C D 1 year 5 years 
F no no no 94.3 _+ 0.2% 70.8 + 0.7% 
F no no yes 91.7 + 0.3% 60.1 + 1.0% 
F yes no no 90.5 + 0.3% 55.4 + 1.2% 
M no no no 90.4 _+ 0.3% 55.1 + 1.2% 
F no yes no 86.5 + 0.4% 42.5 ± 1.7% 
F yes no yes 86.3 + 0.4% 41.9 + 1.7% 
M no no yes 86.2 + 0.5% 41.6 ± 1.7% 
M yes no no 84.1 + 0.5% 36.1 + 2.0% 
F no yes yes 80.8 + 0.6% 28.4 + 2.5% 
F yes yes no 78.1 + 0.8% 23.2 + 2.9% 
M no yes no 77.9 -+ 0.8% 22.9 + 2.9% 
M yes no yes 77.5 -+ 0.8% 22.3 -+ 3.0% 
F yes yes yes 69.4 ± 1.1% 11.6 + 4.3% 
M no. yes yes 69.2 _+ 1.1% 11.4 _+ 4.3% 
M yes yes no 65.2 ± 1.3% 8.0 _+ 5.0% 
M yes yes yes 53.3 ± 1.9% 2.4 _+ 7.3% 
A, Gender; B, diabetes; C, creatinine l vel 1.7 mg/dl or greater; 
D, history of cerebrovascular disease. 
reader that the results may not  be generalizable to 
patients who are undergo ing reversed or nonreversed 
vein bypass or prosthetic bypass. 
In our  patients, men had significantly lower 5- 
and 7-year survival rates when compared with 
women (42.6% _+ 4.1% and 30.9% -+ 4.6% vs 56.9% 
-+ 6.2% and 43.9% _+ 7.1%, respectively). This gender 
relationship is in keeping with the higher annual 
mortal i ty rate observed in men from all cardiovascu- 
lar diseases in an age-standardized Canadian popula-  
l ion. 23,24 In men, the annual mortal i ty rate that re- 
sulted from cardiovascular disease was 315 per 
100,000 per year, compared with 187 per 100,000 
per year for women.  23,24 Our  results are in contrast 
to a previous s tudy  by Magnant  and associates, 2~
where the survival rate at 3 years was 54% in women 
and 72% in men. Our  3-year survival rate was 72% in 
women compared with 59% in men. The women in 
our series were older on average (70 years vs 67 
years), but  the reason for the reversal o f  late survival 
results is not  apparent. 
Diabetes was an important  predictor  because pa- 
tients with diabetes had significantly shorter 5- and 
7-year survival rates compared with those who did 
not  (32.5% + 5.5% and 28.2% + 5.5% vs 54.2% + 
4.4% and 39.1% +5.1%, respectively). Diabetes 
would  be expected to be an important  factor because 
it is associated with diffuse atherosclerosis a well as 
the presence o f  comorb id  medical disease, z6 
Our  patients who had renal insufficiency had a 
significantly lower 5- and 7-year survival rates than 
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Fig. 3. Cumulative survival data (Cox regression) for all 
combinations of significant variables (a, four variables ab- 
sent; b, one variable present; c, two variables present; d, 
three variables present; e, four variables present): 
those who had normal  renal function (20.6% _+ 8.6% 
and 7.7% -+ 6.7% vs 49.9% -+ 3.7% and 38.3% :_~ 
4.2%, respectively). To create a categoric variable, 
renal insufficiency was defined as an abnormal  creati- 
nine level greater than 1.7 mg/d l  or 150 SI units, 
and the significant subgroup difference in survival 
rate at this cutpoint  was unexpected. Of  the 44 
patients who had a creatinine level greater than 1.7 
mg/d l  or 150 SI units, only six were on dialysis 
(three hemodialysis and three peritoneal dialysis). In 
patients who had end-stage renal failure, the de- 
creased long-term survival rate is not  surprising. 
Sanchez et al. 27 reported that the 2-year survival rate 
was only 45.6% and recommended consideration o f  
pr imary amputat ion in those patients who have unre- 
lenting infection or mid-forefoot  gangrene. The as- 
sociation o f  decreased late survival rate at lesser de- 
grees of  renal dysfunction is o f  potential  value in  
patient selection, particularly if it coexists with other 
independent  predictors. 
A history o f  cerebrovascular disease predicts a 
lower survival rate (30.9% _+ 7.1% and 20.6% +_ 6.9% 
vs 51.6% + 3.9% and 38.4% + 4.5% at 5 and 7 years, 
respectively). That a patient has had symptomatic 
arterial disease in more than one vascular bed is a 
warning that diffuse atherosclerosis  present, and 
the patient is at higher risk for cardiac or cerebrovas- 
cular death. Even diffuse disease o f  the legs appears 
to be a predictor of  lower survival rate. Kram and 
colleagues 19 reported that the presence o f  an isolated 
popl iteal segment,  which denotes diffuse tibial dis- 
ease, is associated with l imited life expectancy (38% at 
5 years) because o f  associated coronary disease. Al- 
though by univariate analysis coronary artery disease 
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was significantly associated with late survival (p < 
0.004), this variable was not retained in the multivar- 
iate model as an independent predictor because of 
the prevalence. 
With the worst-case scenario-male g nder, diabe- 
tes, chronic renal insufficiency (creatinine level 
greater than or equal to 1.7 mg/dl  or 150 SI units) 
and a history ofcerebrovascular disease-the predicted 
cumulative 5-year survival rate was 2%, compared 
with the best scenario (female gender, nondiabetic, 
normal renal function, no history of cerebrovascular 
disease), in which the cumulative 5-year survival rate 
was 71%. The survival rate was 43% to 60% when one 
variable was present, 23% to 42% when two variables 
were present, and 8% to 22% when three were 
present. 
CONCLUSION 
The results of this paper illustrate that certain 
preoperative variables are predictive of lower late 
survival rates after distal bypass urgery-male gender, 
diabetes, chronic renal insufficiency (creatinine level 
1.7 mg/dl  or 150 SI units or greater), and a history 
of cerebrovascular disease. If a patient has a poor 
chance of late survival and is not likely to obtain 
prompt and good functional recovery, an aggressive 
distal revascularization procedure might not be war- 
ranted, and the best palliation may be obtained by 
primary amputation. 
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